Selective breeding for helplessness in rats alters the metabolic profile of the hippocampus and frontal cortex: A 1H-MRS study at 9.4 T

International Journal of Neuropsychopharmacology

Volumn 16, Issue 1, 2013, Pages 199-212

  Schulz, Daniela ^a   Smith, David ^a,b   Yu, Mei ^a,b   Lee, Hedok ^b   Henn, Fritz A ^a,c  

^a BROOKHAVEN NATIONAL LABORATORY   (United States)

^b STONY BROOK UNIVERSITY   (United States)

^c Cold Spring Harbor Laboratory ^*  (United States)

Author keywords

Depression; energy metabolism; learned helplessness; proton spectroscopy

Indexed keywords

CHOLINE; CREATINE PHOSPHATE; GLUTAMIC ACID; PHOSPHOLIPID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL STRESS; COGNITION; CONGENITAL LEARNED HELPLESS; CONTROLLED STUDY; DEPRESSION; DISEASE MARKER; EMOTIONALITY; EXCITOTOXICITY; FRONTAL CORTEX; HIPPOCAMPUS; LEARNED HELPLESSNESS; MALE; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; RAT; STRESS; WILD TYPE;

ANIMALS; BREEDING; FRONTAL LOBE; HELPLESSNESS, LEARNED; HIPPOCAMPUS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROTONS; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84871508753     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145711001994     Document Type: Article

References (84)

1. Altamura C, Maes M, Dai J, Meltzer HY (1995). Plasma concentrations of excitatory amino acids, serine, glycine, taurine and histidine in major depression. European Neuropsychopharmacology 5 (Suppl.), 71-75.
2. Altamura CA, Mauri MC, Ferrara A, Moro AR, et al. (1993). Plasma and platelet excitatory amino acids in psychiatric disorders. American Journal of Psychiatry 150, 1731-1733.
3. Auer DP, Pü tz B, Kraft E, Lipinski B, et al. (2000). Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study. Biological Psychiatry 47, 305-313.
4. Bartus RT, Dean III RL, Beer B, Lippa AS (1982). The cholinergic hypothesis of geriatric memory dysfunction. Science 217, 408-414.
5. Beal MF (1995). Aging, energy, and oxidative stress in neurodegenerative diseases. Annals of Neurology 38, 357-366.
6. Bechtholt-Gompf AJ, Smith KL, John CS, Kang HH, et al. (2011). CD-1 and Balb/cJ mice do not show enduring antidepressant-like effects of ketamine in tests of acute antidepressant efficacy. Psychopharmacology 215, 689-695.
7. Berman RM, Cappiello A, Anand A, Oren DA, et al. (2000). Antidepressant effects of ketamine in depressed patients. Biological Psychiatry 47, 351-354.
8. Bhagwagar Z, Wylezinska M, Jezzard P, Evans J, et al. (2007). Reduction in occipital cortex gamma-aminobutyric acid concentrations in medication-free recovered unipolar depressed and bipolar patients. Biological Psychiatry 61, 806-812.
9. Biedermann S, Weber-Fahr W, Zheng L, Hoyer C, et al. (in press). Increase of hippocampal glutamate after electroconvulsive treatment: a quantitative proton MR spectroscopy study at 9.4 T in an animal model of depression. World Journal of Biological Psychiatry.
10. Block W, Träber F, von Widdern O, Metten M, et al. (2009). Proton MR spectroscopy of the hippocampus at 3 T in patients with unipolar major depressive disorder : correlates and predictors of treatment response. International Journal of Neuropsychopharmacology 12, 415-422.
11. Boulanger Y, Labelle M, Khiat A (2000). Role of phospholipase A2 on the variations of the choline signal intensity observed by 1H magnetic resonance spectroscopy in brain diseases. Brain Research Reviews 33, 380-389.
12. Capizzano AA, Jorge RE, Acion LC, Robinson RG (2007). In vivo proton magnetic resonance spectroscopy in patients with mood disorders : a technically oriented review. Journal of Magnetic Resonance Imaging 26, 1378-1389.
13. Czeh B, Michaelis T, Watanabe T, Frahm J, et al. (2001). Stress-induced changes in cerebral metabolites, hippocampal volume, and cell proliferation are prevented by antidepressant treatment with tianeptine. Proceedings of the National Academy of Sciences USA 98, 12796-12801.
14. Delgado y Palacios R, Campo A, Henningsen K, Verhoye M, et al.(2011). Magnetic resonance imaging and spectroscopy reveal differential hippocampal changes in anhedonic and resilient subtypes of the chronic mild stress rat model. Biological Psychiatry 70, 449-457.
15. Dere E, Kart-Teke E, Huston JP, De Souza Silva MA (2006). The case for episodic memory in animals. Neuroscience and Biobehavioral Reviews 30, 1206-1224.
16. deVito LM, Eichenbaum H (2010). Distinct contributions of the hippocampus and medial prefrontal cortex to the 'what-where-when' components of episodic-like memory in mice. Behavioural Brain Research 215, 318-325.
17. Duman RS, Monteggia LM (2006). A neurotrophic model for stress-related mood disorders. Biological Psychiatry 59, 1116-1127.
18. El Idrissi A (2008). Taurine increases mitochondrial buffering of calcium: role in neuroprotection. Amino Acids 34, 321-328.
19. El Idrissi A, Boukarrou L, Heany W, Malliaros G, et al. (2009). Effects of taurine on anxiety-like and locomotor behavior of mice. Advances in Experimental Medicine and Biology 643, 207-215.
20. El Idrissi A, Trenkner E (1999). Growth factors and taurine protect against excitotoxicity by stabilizing calcium homeostasis and energy metabolism. Journal of Neuroscience 19, 9459-9468.
21. El Idrissi A, Trenkner E (2004). Taurine as a modulator of excitatory and inhibitory neurotransmission. Neurochemical Research 29, 189-197.
22. Ende G, Braus DF, Walter S, Weber-Fahr W, et al. (2000). The hippocampus in patients treated with electroconvulsive therapy. Archives of General Psychiatry 57, 937-943.
23. Ende G, Demirakca T, Tost H (2006). The biochemistry of dysfunctional emotions: proton MR spectroscopic findings in major depressive disorder. Progress in Brain Research 156, 481-501.
24. Ende G, Demirakca T, Walter S, Wokrina T, et al. (2007). Subcortical and medial temporal MR-detectable metabolite abnormalities in unipolar major depression. European Archives of Psychiatry and Clinical Neuroscience 257, 36-39.
25. Enkel T, Spanagel R, Vollmayr B, SchneiderM(2010). Stress triggers anhedonia in rats bred for learned helplessness. Behavioural Brain Research 209, 183-186.
26. Gruber S, Frey R, Mlynarik V, Stadlbauer A, et al. (2003). Quantification of metabolic differences in the frontal brain of depressive patients and controls obtained by 1H MRS at 3 Tesla. Investigative Radiology 38, 403-408.
27. Hasler G, Van der Veen JW, Tumonis T, Meyers N, et al. (2007). Reduced prefrontal glutamate/glutamine andc-aminobutyric acid levels in major depression determined using proton magnetic resonance spectroscopy. Archives of General Psychiatry 64, 193-200.
28. Heim C, Nemeroff CB (2001). The role of childhood trauma in the neurobiology of mood and anxiety disorders : preclinical and clinical studies. Biological Psychiatry 49, 1023-1039.
29. Henn FA, Vollmayr B (2005). Stress models of depression: forming genetically vulnerable strains. Neuroscience and Biobehavioral Reviews 29, 799-804.
30. Hong ST, Choi CB, Park CS, Hong KS, et al. (2007). Variation of the choline signal intensity in the dorsolateral prefrontal cortex of rats exposed to the forced swimming test as detected by in vivo 1H MR spectroscopy. Journal of Neuroscience Methods 165, 89-94.
31. Hong ST, Choi CB, Park C, Moon HY, et al. (2009). Specific hippocampal choline decrease in an animal model of depression. British Journal of Radiology 82, 549-553.
32. Hui J, Zhang Z, Liu S, Xi G, et al. (2010). Adolescent escitalopram administration modifies neurochemical alterations in the hippocampus of maternally separated rats. European Neuropsychopharmacology 20, 875-883.
33. Huxtable RJ (1989). Taurine in the central nervous system and the mammalian actions of taurine. Progress in Neurobiology 32, 471-533.
34. Huxtable RJ (1992). Physiological actions of taurine. Physiological Reviews 72, 101-163.
35. Jung RE, Yeo RA, Love TM, Petropoulos H, et al. (2002). Biochemical markers of mood: a proton magnetic resonance spectroscopy study of normal human brain. Biological Psychiatry 51, 224-229.
36. Kemp GJ (2000). Non-invasive methods for studying brain energy metabolism: what they show and what it means. Developmental Neuroscience 22, 418-428.
37. Khan ZU, Muly EC (2011). Molecular mechanisms of working memory. Behavioural Brain Research 219, 329-341.
38. Kim S-Y, Lee Y-J, Kim H, Lee D-W, et al. (2010). Desipramine attenuates forced swim test-induced behavioral and neurochemical alterations in mice: an in vivo 1H MRS study at 9.4 T. Brain Research 1348, 105-113.
39. Lambert HI (2004). Regulation of the cellular content of the organic osmolyte taurine in mammalian cells. Neurochemical Research 29, 27-63.
40. Lambert HI (2007). Activation and inactivation of the volume-sensitive taurine leak pathway in NIH3T3 fibroblasts and Ehrlich Lettre ascites cells. American Journal of Physiology. Cell Physiology 293, 390-400.
41. Lehmann A, Hagberg H, Hamberger A (1984). A role for taurine in the maintenance of homeostasis in the central nervous system during hyperexcitation? Neuroscience Letters 52, 341-346.
42. Li C-X, Wang Y, Gao H, Pan W-J, et al. (2008). Cerebral metabolic changes in a depression-like rat model of chronic forced swimming studied by ex vivo high resolution 1H magnetic resonance spectroscopy. Neurochemical Research 33, 2342-2349.
43. Lowy MT, Wittenberg L, Yamamoto BK (1995). Effect of acute stress on hippocampal glutamate levels and spectrin proteolysis in young and aged rats. Journal of Neurochemistry 65, 268-274.
44. Maes M, Verkerk R, Vandoolaeghe E, Lin A, et al. (1998). Serum levels of excitatory amino acids, serine, glycine, histidine, threonine, taurine, alanine and arginine in treatment-resistant depression: Modulation by treatment with antidepressants and prediction of clinical responsivity. Acta Psychiatrica Scandinavica 97, 302-308.
45. Matthews RT, Ferrante RJ, Klivenyi P, Yang L, et al. (1999). Creatine and cyclocreatine attenuate MPTP neurotoxicity. Experimental Neurology 157, 142-149.
46. Mauri MC, Ferrara A, Boscati L, Bravin S, et al. (1998). Plasma and platelet amino acid concentrations in patients affected by major depression and under fluvoxamine treatment. Neuropsychobiology 37, 124-129.
47. Merkl A, Schubert F, Quante A, Luborzewski A, et al. (2011). Abnormal cingulated and prefrontal cortical neurochemistry in major depression after electroconvulsive therapy. Biological Psychiatry 69, 772-779.
48. Milne A, MacQueen GM, Yucel K, Soreni N, et al. (2009). Hippocampal metabolic abnormalities at first onset and with recurrent episodes of a major depressive disorder : a proton magnetic resonance spectroscopy study. Neuroimage 47, 36-41.
49. Mineka S, Watson D, Clark LA (1998). Comorbidity of anxiety and unipolar mood disorders. Annual Review of Psychology 49, 377-412.
50. Mitani H, Shirayama Y, Yamada T, Maeda K, et al. (2006). Correlation between plasma levels of glutamate, alanine and serine with severity of depression. Progress in Neuro-Psychopharmacology and Biological Psychiatry 30, 1155-1158.
51. Moghaddam B (1993). Stress preferentially increases extraneuronal levels of excitatory amino acids in the prefrontal cortex : comparison to hippocampus and basal ganglia. Journal of Neurochemistry 60, 1650-1657.
52. Morris RGM, Garrud P, Rawlins JNP, O'Keefe J (1982). Place navigation impaired in rats with hippocampal lesions. Nature 297, 681-683.
53. Murakami T, Furuse M (2010). The impact of taurine-and beta-alanine-supplemented diets on behavioral and neurochemical parameters in mice: antidepressant vs. anxiolytic-like effects. Amino Acids 39, 427-434.
54. Nery FG, Stanley JA, Chen HH, Hatch JP, et al. (2009). Normal metabolite levels in the left dorsolateral prefrontal cortex of unmedicated major depressive disorder patients : a single voxel (1) H spectroscopy study. Psychiatry Research 174, 177-183.
55. Nestler EJ, Barrot M, DiLeone RJ, Eisch AJ, et al. (2002). Neurobiology of depression. Neuron 34, 13-25.
56. Olive MF, Mehmert KK, Hodge CW (2000). Modulation of extracellular neurotransmitter levels in the nucleus accumbens by a taurine uptake inhibitor. European Journal of Pharmacology 409, 291-294.
57. Olney JW, Wozniak DF, Farber NB (1997). Excitotoxic neurodegeneration in Alzheimer disease : new hypothesis and new therapeutic strategies. Archives of Neurology 54, 1234-1240.
58. Peterson C, Maier SF, Seligman MEP (1993). Learned Helplessness : A Theory for the Age of Personal Control. New York: Oxford University Press.
59. Pfefferbaum A, Adalsteinsson E, Spielman D, Sullivan EV, et al. (1999). In vivo spectroscopic quantification of the N-acetyl moiety, creatine, and choline from large volumes of brain gray and white matter: effects of normal aging. Magnetic Resonance in Medicine 41, 276-284.
60. Pfleiderer B, Michael N, Erfurth A, Ohrmann P, et al. (2003). Effective electroconvulsive therapy reverses glutamate/glutamine deficit in the left anterior cingulum of unipolar depressed patients. Psychiatry Research 122, 185-192.
61. Popik P, Kos T, Sowa-Kucma M, Nowak G (2008). Lack of persistent effects of ketamine in rodent models of depression. Psychopharmacology 198, 421-430.
62. Provencher SW(2001). Automatic quantitation of localized in vivo 1H spectra with LCModel. NMR in Medicine 14, 260-264.
63. Rada P, Moreno SA, Tucci S, Gonzalez LE, et al. (2003). Glutamate release in the nucleus accumbens is involved in behavioral depression during the Porsolt swim test. Neuroscience 119, 557-565.
64. Reznikov LR, Grillo CA, Piroli GG, Pasumarthi RK, et al. (2007). Acute stress-mediated increases in extracellular glutamate levels in the rat amygdala: differential effects of antidepressant treatment. European Journal of Neuroscience 25, 3109-3114.
65. Rosenberg DR, MacMaster FP, Mirza Y, Smith JM, et al. (2005). Reduced anterior cingulated glutamate in pediatric major depression: a magnetic resonance spectroscopy study. Biological Psychiatry 58, 700-704.
66. Sanacora G, Gueorguieva R, Epperson CN, Wu YT, et al. (2004). Subtype-specific alterations of gammaaminobutyric acid and glutamate in patients with major depression. Archives of General Psychiatry 61, 705-713.
67. Sartorius A, Mahlstedt MM, Vollmayr B, Henn FA, et al. (2007). Elevated spectroscopic glutamate/c-amino butyric acid in rats bred for learned helplessness. NeuroReport 18, 1469-1473.
68. Sartorius A, Vollmayr B, Neumann-Haefelin C, Ende G, et al. (2003). Specific creatine rise in learned helplessness induced by electroconvulsive shock treatment. NeuroReport 14, 2199-2201.
69. Schulz D, Mirrione MM, Henn FA (2010). Cognitive aspects of congenital learned helplessness and its reversal by the monoamine oxidase (MAO)-B inhibitor deprenyl. Neurobiology of Learning and Memory 93, 291-301.
70. Seligman MEP (1975). Helplessness. San Francisco: Freeman.
71. Shajan G, Hoffmann J, Budde J, Adriany G, et al. (2011). Design and evaluation of an RF front-end for 9.4 T human MRI. Magnetic Resonance in Medicine. Published online : 4 March 2011. doi :10.1002/mrm.22808.
72. Shumake J, Barrett D, Gonzalez-Lima F (2005). Behavioral characteristics of rats predisposed to learned helplessness : reduced reward sensitivity, increased novelty seeking, and persistent fear memories. Behavioural Brain Research 164, 222-230.
73. Sonawalla SB, Renshaw PF, Moore CM, Alpert JE, et al. (1999). Compounds containing cytosolic choline in the basal ganglia: a potential biological marker of true drug response to fluoxetine. American Journal of Psychiatry 156, 1638-1640.
74. Taylor MJ, Mannie ZN, Norbury R, Near J, et al. (2010). Elevated cortical glutamate in young people at increased familial risk of depression. International Journal of Neuropsychopharmacology 16, 1-5.
75. Tokita K, Yamaji T, Hashimoto K (2011). Roles of glutamate signaling in preclinical and/or mechanistic models of depression. Pharmacology, Biochemistry, and Behavior. Published online : 21 April 2011. doi:10.1016/j.pbb.2011.04.016.
76. Trullas R, Skolnick P (1990). Functional antagonists at the NMDA receptor complex exhibit antidepressant actions. European Journal of Pharmacology 185, 1-10.
77. Tulving E, Markowitsch HJ (1998). Episodic and declarative memory: role of the hippocampus. Hippocampus 8, 198-204.
78. Ulus IH, Wurtman RJ, Mauron C, Blusztajn JK (1989). Choline increases acetylcholine release and protects against the stimulation-induced decrease in phosphatide levels within membranes of rat corpus striatum. Brain Research 484, 217-227.
79. Vollmayr B, Bachteler D, Vengeliene V, Gass P, et al. (2004). Rats with congenital learned helplessness respond less to sucrose but show no deficits in activity or learning. Behavioural Brain Research 150, 217-221.
80. Vollmayr B, Henn FA (2001). Learned helplessness in the rat : improvements in validity and reliability. Brain Research Protocols 8, 1-7.
81. Wieland S, Boren JL, Consroe PF, Martin A (1986). Stock differences in the susceptibility of rats to learned helplessness training. Life Sciences 39, 937-944.
82. Wurtman RJ (1992). Choline metabolism as a basis for the selective vulnerability of cholinergic neurons. Trends in Neurosciences 15, 117-122.
83. Yilmaz A, Schulz D, Aksoy A, Canbeyli R (2002). Prolonged effect of an anesthetic dose of ketamine on behavioral despair. Pharmacology, Biochemistry, and Behavior 71, 341-344.
84. Yuh WT, Christoforidis GA, Koch RM, Sammet S, et al. (2006). Clinical magnetic resonance imaging of brain tumors at ultrahigh field : a state-of-the-art review. Topics in Magnetic Resonance Imaging 17, 53-61.